GlassScriptPhysician profile
Carlos A Leche
NPI 1417956707
$5,287.16
in general payments reported to CMS, 2019-2025
34 companies · $981 in 2025
The $981 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $354 · 2021: $399 · 2022: $1,164 · 2023: $902 · 2024: $916 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,571 · Travel and Lodging: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,571.21 |
| Travel and Lodging | $227.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $646.96 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $572.97 | 2019-2025 | Farxiga |
| Medtronic, INC. | $419.02 | 2022-2023 | Reveal Linq |
| Boston Scientific Corporation | $403.43 | 2019-2025 | General - Therapies, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $381.33 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $359.43 | 2019-2025 | |
| Abbott Laboratories | $308.48 | 2019-2025 | Jot Dx, Mitraclip, Triclip |
| Pfizer INC. | $236.52 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.45 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $186.14 | 2019-2023 | Diamondback Coronary |
| Kestra Medical Technology Services, INC. | $168.78 | 2022-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $163.38 | 2019-2023 | Xarelto |
| Amgen INC. | $158.77 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $144.57 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Impulse Dynamics (USA) INC. | $93.60 | 2023-2024 | Optimizer, Optimizer |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $78.54 | 2024-2025 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $70.03 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $66.79 | 2019-2021 | |
| Abiomed | $64.47 | 2019-2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $63.16 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $57.49 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $55.72 | 2022-2023 | Eliquis, Camzyos |
| Penumbra, INC. | $48.23 | 2022-2023 | Indigo System |
| Scpharmaceuticals INC. | $39.23 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $35.66 | 2023-2024 | Inpefa |
| Philips North America LLC | $33.48 | 2024 | (Ck4) Mcot |
| Cook Medical LLC | $31.44 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $30.73 | 2022-2023 | Arcalyst |
| Astellas Pharma US INC | $29.65 | 2019-2021 | |
| Preventice Services, LLC | $28.79 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $25.65 | 2024 | Arcalyst |
| Biotronik INC. | $23.64 | 2024 | Biomonitor |
| Bard Peripheral Vascular, INC. | $19.61 | 2022 | |
| Vital Connect, INC | $17.02 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Leche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.